2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CANCER INVESTIGATION CANCER INVEST (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.3
51人评分
我要评分
声誉 6.4 影响力 3.9 速度 8.7 | |||||||||||||||||||||
期刊ISSN | 0735-7907 | 微信扫码收藏此期刊 | ||||||||||||||||||||
E-ISSN | 1532-4192 | |||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 1.8 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:1.191 | |||||||||||||||||||||
2023-2024自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 2.1 | |||||||||||||||||||||
JCI期刊引文指标 | 0.39 | |||||||||||||||||||||
h-index | 77 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | http://www.tandfonline.com/toc/icnv20/current#.V4hzokz9cSQ | |||||||||||||||||||||
期刊投稿网址 | https://mc.manuscriptcentral.com/lcnv | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER INVESTIGATION的语言要求,还能让CANCER INVESTIGATION编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER INVESTIGATION编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||
通讯方式 | TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106 | |||||||||||||||||||||
出版商 | Informa Healthcare | |||||||||||||||||||||
涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||
出版年份 | 1983 | |||||||||||||||||||||
年文章数 | 53点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 7.62% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 83.02% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:3区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0735-7907%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均8.5月 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 约50% | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在CANCER INVESTIGATION顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Trends and Projections of Stomach Cancer Incidence in Hong Kong: A Population-Based Study Author: Yang, Liping; Sun, Haifeng; Bai, Yan; Sun, Shengzhi; Wu, Xiaoming; Gan, Zhenhai; Du, Jianqiang; Du, Jianfei Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 319-329. DOI: 10.1080/07357907.2022.2126982 PubMed DOI |
2. | Tumoral Overexpression of Hepcidin is Associated with Poor Prognosis of Patients with Clear Cell Renal Cell Carcinoma Author: Qiu, Huizhu; Gu, Guojian; Zuo, Erdong; Cheng, Xu Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 1, pp. 84-92. DOI: 10.1080/07357907.2022.2133775 PubMed DOI |
3. | The Prognostic Value of ADAMTS8 and Its Role as a Tumor Suppressor in Breast Cancer Author: Zhang, Qia; Kanyomse, Quist; Luo, Chenghao; Mo, Qingfan; Zhao, XunPing; Wang, Long; Peng, Weiyan; Ren, Guosheng Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 2, pp. 119-132. DOI: 10.1080/07357907.2022.2128367 PubMed DOI |
4. | A DNA Damage Response Related Signature to Predict Prognosis in Patients with Acute Myeloid Leukemia Author: Wang, Jun; Wu, Jiafei; Wang, Yijing; Wang, Yu; Jiang, Chuanyan; Zou, Mengying; Jin, Xiaokang; Sun, Xiaoran; Zhang, Yu; Ma, Sijia; Wang, Guoqiang; Zhu, Xin; Lu, Huafei; Xu, Chunwei; Wang, Wenxian; Li, Leo; Han, Yusheng; Cai, Shangli; Li, Hui Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 3, pp. 271-283. DOI: 10.1080/07357907.2023.2167209 PubMed DOI |
5. | Efficacy and Safety of Bevacizumab for Treating Glioblastoma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials Author: Xie, Xiaohong; Bao, Shangyi; Zhao, Hong; Li, Liuying; Fu, Xiaojun Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 3, pp. 305-317. DOI: 10.1080/07357907.2023.2174261 PubMed DOI |
6. | Poorly Controlled Diabetes Mellitus Increases the Risk of Deaths and Castration-Resistance in Locally Advanced Prostate Cancer Patients Author: Ma, Cheng; Cui, Di; Han, Bangmin; Ding, Mao; Zhang, Jiahao; Liu, Shiyun; Gao, Yingli; Xia, Shujie Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 345-353. DOI: 10.1080/07357907.2023.2171050 PubMed DOI |
7. | Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps Author: Tu, Yaofen; Mao, Zujie Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 354-368. DOI: 10.1080/07357907.2023.2179063 PubMed DOI |
8. | Bioinformatics Identification and Validation of Aging-Related Molecular Subtype and Prognostic Signature in Sarcoma Author: Hong, Xu; Liu, Hui; Chen, Chu; Lai, Tian; Lin, Jingui Journal: CANCER INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2023.2209638 PubMed DOI |
9. | Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma Author: Sun, Lili; Yao, Xingmei; Liu, Jingmei; Zhang, Yu; Hu, Jian Journal: CANCER INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2023.2194420 PubMed DOI |
10. | Conversion Surgery for Unresectable Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Author: Du R1, Hu P2, Liu Q3, Zhang J2. Journal: Cancer Invest. 2019;37(1):16-28. doi: 10.1080/07357907.2018.1551898. Epub 2019 Jan 11. PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室